Study finds digital CBT for children with anxiety delivers on par with traditional methods, lowers costs

If digitally augmented, therapist-supported, parent-led CBT is a cost-effective and clinically effective alternative.

Tomivosertib hydrochloride by EFFECTOR Therapeutics for Non-Small Cell Lung Cancer: Likelihood of Approval

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes

October 27, 2023

Study proposes new model for treating stress-related exhaustion

A new thesis at Uppsala University questions the traditional view of stress-induced exhaustion disorder. A new model is proposed in its place that puts more

June 17, 2024

Pharmalittle: We’re reading about Cigna biosimilar plans, a Vertex deal in South Africa, and more

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal

April 26, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.